Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study
Annals of the Rheumatic Diseases · 2024
DOI: 10.1136/ard-2023-224965 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Annals of the Rheumatic Diseases, 2024. Verfasst von Sofia Exarchou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences Malmö, Rheumatology, Lund University, Malmö, Sweden. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Cardiovascular Diseases. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Reumatikerförbundet, Eli Lilly, Pfizer.
Abstract (Originalsprache)
OBJECTIVES: To compare all-cause mortality and causes of death between patients with psoriatic arthritis (PsA) and the general population in Sweden. METHODS: Adults with at least one main PsA diagnosis (International Classification of Diseases-10: L40.5/M07.0-M07.3) from outpatient rheumatology/internal medicine departments 2001-2017 were identified from the National Patient Register. Each case was matched to five population comparator-subjects on sex/county/age at the case's first arthritis diagnosis. Follow-up ran from 1 January 2007, or from first PsA diagnosis thereafter, until death, emigration or 31 December 2018. Mortality was assessed overall, and stratified by sex and duration since diagnosis (diagnosis before/after 1 January 2007), using matched Cox proportional hazard regression (excluding/including adjustments for comorbidity) or Breslow test, as appropriate. Incidence rate ratios (IRR) of death, overall and stratified by sex/duration since diagnosis/age, as well as causes of death in PsA cases and comparator-subjects were also described. RESULTS: All-cause mortality was elevated in PsA (HR: 1.11 (95% CI: 1.07 to 1.16); IRR: 1.18 (95% CI: 1.13 to 1.22)), mainly driven by increased risks in women (HR: 1.23 (95% CI: 1.16 to 1.30)) and cases with longer time since diagnosis (HR: 1.18 (95% CI: 1.12 to 1.25)). IRR of death were significantly increased for all ages except below 40 years, with the numerically highest point-estimates for ages 40-59 years. When adjusted for comorbidity, however, the elevated mortality risk in PsA disappeared. Causes of death were similar among PsA cases/comparator-subjects, with cardiovascular disease and malignancy as the leading causes. CONCLUSIONS: Mortality risk in PsA in Sweden was about 10% higher than in the general population, driven by excess comorbidity and with increased risks mainly in women and patients with longer disease duration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Sciences Malmö, Rheumatology, Lund University, Malmö, Sweden.
- Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
- Department of Rheumatology and Inflammation Research, University of Gothenburg Sahlgrenska Academy, Gothenburg, Sweden.
- Department of Rheumatology, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Center for Clinical Research Dalarna, Uppsala University, Uppsala, Sweden.
- Department of Rheumatology, Falun Hospital, Falun, Sweden.
Förderung
- Reumatikerförbundet
- Eli Lilly
- Pfizer
- Psoriasisfonden
- AbbVie
- Gösta A Karlssons 60-årsfond
- Novartis
- Amgen
Zitieren
APA
Exarchou, S., Di Giuseppe, D., Klingberg, E., Sigurdardottir, V., Wedrén, S., Lindström, U., Turesson, C., Jacobsson, L. T. H., Askling, J., & Wallman, J. K. (2024). Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study. Annals of the Rheumatic Diseases. https://doi.org/10.1136/ard-2023-224965
Vancouver
Exarchou S, Di Giuseppe D, Klingberg E, Sigurdardottir V, Wedrén S, Lindström U, et al. Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study. Annals of the Rheumatic Diseases. 2024. doi:10.1136/ard-2023-224965
BibTeX
@article{Exarchou2024,
author = {Exarchou, Sofia and Di Giuseppe, Daniela and Klingberg, Eva and Sigurdardottir, Valgerdur and Wedrén, Sara and Lindström, Ulf and Turesson, Carl and Jacobsson, Lennart T H and Askling, Johan and Wallman, Johan K},
title = {Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study},
journal = {Annals of the Rheumatic Diseases},
year = {2024},
doi = {10.1136/ard-2023-224965}
}
EUVIMED